Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-15

Clinical Trial Update: Fluoxetine vs Aripiprazole Comparative Trial (FACT) [Phase 4]

View source ↗

Summary

Phase 4 comparative trial comparing fluoxetine vs aripiprazole for attenuated psychosis syndrome was terminated with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)
  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: Northwell Health | Conditions: Attenuated Psychosis Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2023-11-15